Results 141 to 150 of about 23,209 (275)

Is anti-cholinesterase therapy of Alzheimer's disease delaying progression? [PDF]

open access: yes, 2018
During the last decade, a systematic effort to develop a pharmacological treatment for Alzheimer's disease (AD) resulted in three drugs being registered for the first time in the US and Europe.
Giacobini, E.
core  

Switching from Donepezil or Rivastigmine to Galantamine in Clinical Practice [PDF]

open access: bronze, 2004
Keith R. Edwards   +2 more
openalex   +1 more source

Comparison of two pharmaceutical production processes using different eco-efficiency measuring methods [PDF]

open access: yes, 2011
Aelterman, Wim   +7 more
core   +1 more source

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

open access: yesClinical Interventions in Aging, 2008
Richard A Hansen1, Gerald Gartlehner2, Aaron P Webb1, Laura C Morgan3, Charity G Moore4, Daniel E Jonas31School of Pharmacy, 3Cecil G Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA; 2Department for Evidence ...
Richard A Hansen   +5 more
doaj  

GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE [PDF]

open access: bronze, 2008
Frédéric Assal   +4 more
openalex   +1 more source

Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats [PDF]

open access: bronze, 2008
Charlotte Wiker   +4 more
openalex   +1 more source

Ameliorative effect of galantamine on acetic acid-induced colitis in rats

open access: gold, 2019
Mohsen Minaiyan   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy